RIO DE JANEIRO, BRAZIL - The stem cell and virus banks that will allow the vaccine developed by the Anglo-Swedish laboratory AstraZeneca to be produced locally and with total autonomy in Brazil arrived this Wednesday, June 2, in Rio de Janeiro, the Oswaldo Cruz Foundation (Fiocruz) has advised.
The material - which allows the creation of the active pharmaceutical ingredient (API), a biological component considered the "heart" of the vaccine - arrived in Brazil just one day after the transfer of technology for the manufacture of the raw materials to Fiocruz was confirmed, thus giving the country total autonomy for the manufacture . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here